Literature DB >> 1102454

Properties of lymphocytes in chronic HBAg-positive hepatitis. An approach to pathogenetic problems.

P Tolentino, M Pasino, A Braito, R Giacchino, A Astaldi.   

Abstract

Lymphocytes from 22 children affected by chronic hepatitis were studied and a comparison was made with a control group of 32 healthy children in the same age range with respect to PHA dose-response curves. E-rosette formation and membrane immunoglobulin (Ig). From the results it appeared that PHA dose-response curves were displaced to the left (low PHA dose), DNA synthesis was significantly higher for all PHA dosages tested, and that the plasma of chronic hepatitis patients acted neither as inhibitor nor stimulator. The percentage of E-rosette-forming cells decreased, but the total number was normal. The mean percentage of Ig-bearing cells was normal but the single values were spaced over a wide range. It can be assumed that, at least in the chronic stage, there is an enhanced response to PHA and an increased percentage of cells without markers either for T or for B cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1102454     DOI: 10.1007/bf01641046

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  In vitro methods in cell-mediated immunity: a progress report.

Authors: 
Journal:  Cell Immunol       Date:  1973-03       Impact factor: 4.868

2.  Lymphocyte transformation and persistent Australia antigen.

Authors:  A I Sutnick; W T London; B S Blumberg
Journal:  Lancet       Date:  1973-05-19       Impact factor: 79.321

3.  Letter: Persistence of Au-SH antigen and lymphocyte transformation.

Authors:  I B Petri; E J Mészáros
Journal:  Lancet       Date:  1973-10-06       Impact factor: 79.321

4.  Inhibitory effect of Australia-positive sera on in-vitro-stimulated T lymphocytes.

Authors:  J Clot; O Mathieu; S Elharrar; M Robinet-Levy; J M Lemaire
Journal:  Lancet       Date:  1973-09-08       Impact factor: 79.321

5.  Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen.

Authors:  V Giustino; F J Dudley; S Sherlock
Journal:  Lancet       Date:  1972-10-21       Impact factor: 79.321

6.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

7.  An immunofluorescence procedure for the detection of intracellular immunoglobulins.

Authors:  W Hijmans; H R Schuit; F Klein
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

8.  Aquisition of hepatitis-associated antigen. Clinical features in young adults.

Authors:  L F Barker; R Murray
Journal:  JAMA       Date:  1971-06-21       Impact factor: 56.272

9.  [Chronic viral hepatitis in childhood. 24 cases including 5 sibling pairs].

Authors:  P Tolentino
Journal:  Infection       Date:  1973       Impact factor: 3.553

10.  Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture.

Authors:  F Paronetto; S Vernace
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

  10 in total
  3 in total

1.  T and B lymphocytes in patients with chronic active hepatitis (CAH).

Authors:  M Colombo; S J Vernace; F Paronetto
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

2.  Chronic active hepatitis in patients with and without hepatitis B surface antigenemia.

Authors:  A Pár; K Barna; G Bajtai; M Balázs; A Patakfalvi; A Gógl
Journal:  Infection       Date:  1977       Impact factor: 3.553

3.  Immunosuppressive treatment of chronic HBsAg-positive hepatitis in childhood.

Authors:  P Tolentino; C Jannuzzi; R Giacchino
Journal:  Infection       Date:  1983 Sep-Oct       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.